フォロー
Shingo Iwami
Shingo Iwami
iBLab, Graduate School of Science, Nagoya University, Japan
確認したメール アドレス: bio.nagoya-u.ac.jp - ホームページ
タイトル
引用先
引用先
SVIR epidemic models with vaccination strategies
X Liu, Y Takeuchi, S Iwami
Journal of Theoretical biology 253 (1), 1-11, 2008
3142008
Avian–human influenza epidemic model
S Iwami, Y Takeuchi, X Liu
Mathematical biosciences 207 (1), 1-25, 2007
2542007
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
M Iwamoto, W Saso, R Sugiyama, K Ishii, M Ohki, S Nagamori, R Suzuki, ...
Proceedings of the National Academy of Sciences 116 (17), 8487-8492, 2019
2152019
Cell-to-cell infection by HIV contributes over half of virus infection
S Iwami, JS Takeuchi, S Nakaoka, F Mammano, F Clavel, H Inaba, ...
elife 4, e08150, 2015
1612015
A heart–brain–kidney network controls adaptation to cardiac stress through tissue macrophage activation
K Fujiu, M Shibata, Y Nakayama, F Ogata, S Matsumoto, K Noshita, ...
Nature medicine 23 (5), 611-622, 2017
1472017
Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells
M Mahgoub, J Yasunaga, S Iwami, S Nakaoka, Y Koizumi, K Shimura, ...
Proceedings of the National Academy of Sciences 115 (6), E1269-E1278, 2018
1442018
Optimal control strategy for prevention of avian influenza pandemic
E Jung, S Iwami, Y Takeuchi, TC Jo
Journal of theoretical biology 260 (2), 220-229, 2009
1362009
Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy
M Horiike, S Iwami, M Kodama, A Sato, Y Watanabe, M Yasui, Y Ishida, ...
Virology 423 (2), 107-118, 2012
1352012
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
H Ohashi, K Watashi, W Saso, K Shionoya, S Iwanami, T Hirokawa, ...
Iscience 24 (4), 2021
1212021
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
KS Kim, K Ejima, S Iwanami, Y Fujita, H Ohashi, Y Koizumi, Y Asai, ...
PLoS biology 19 (3), e3001128, 2021
1092021
APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model
K Sato, JS Takeuchi, N Misawa, T Izumi, T Kobayashi, Y Kimura, S Iwami, ...
PLoS pathogens 10 (10), e1004453, 2014
952014
Avian flu pandemic: can we prevent it?
S Iwami, Y Takeuchi, X Liu
Journal of theoretical biology 257 (1), 181-190, 2009
882009
Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice
K Sato, N Misawa, M Fukuhara, S Iwami, DS An, M Ito, Y Koyanagi
Journal of virology 86 (9), 5000-5013, 2012
792012
The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network
M Iwamoto, W Saso, K Nishioka, H Ohashi, R Sugiyama, A Ryo, M Ohki, ...
Journal of Biological Chemistry 295 (3), 800-807, 2020
752020
Multidrug treatment with nelfinavir and cepharanthine against COVID-19
H Ohashi, K Watashi, W Saso, K Shionoya, S Iwanami, T Hirokawa, ...
BioRxiv, 2020.04. 14.039925, 2020
682020
Factors associated with COVID-19 vaccine booster hesitancy: A retrospective cohort study, Fukushima vaccination community survey
M Yoshida, Y Kobashi, T Kawamura, Y Shimazu, Y Nishikawa, F Omata, ...
Vaccines 10 (4), 515, 2022
642022
A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain
Y Kakizoe, S Nakaoka, CAA Beauchemin, S Morita, H Mori, T Igarashi, ...
Scientific reports 5 (1), 10371, 2015
622015
Dynamical properties of autoimmune disease models: tolerance, flare-up, dormancy
S Iwami, Y Takeuchi, Y Miura, T Sasaki, T Kajiwara
Journal of theoretical biology 246 (4), 646-659, 2007
602007
Estimation of the incubation period of COVID-19 using viral load data
K Ejima, KS Kim, C Ludema, AI Bento, S Iwanami, Y Fujita, H Ohashi, ...
Epidemics 35, 100454, 2021
562021
Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection
Y Koizumi, H Ohashi, S Nakajima, Y Tanaka, T Wakita, AS Perelson, ...
Proceedings of the National Academy of Sciences 114 (8), 1922-1927, 2017
562017
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20